Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvemen...
Journal Information
Vol. 148. Issue 1.
Pages 1-7 (January 2017)
Share
Share
Download PDF
More article options
Visits
14
Vol. 148. Issue 1.
Pages 1-7 (January 2017)
Original article
Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases
Vasculitis asociada a anticuerpos contra el citoplasma de neutrófilo con afectación renal: análisis de 89 casos
Visits
14
Fernando Caravaca-Fontán
Corresponding author
fcaravacaf@gmail.com

Corresponding author.
, Estefanía Yerovi, María Delgado-Yagüe, Cristina Galeano, Saúl Pampa-Saico, Maria Teresa Tenorio, Fernando Liaño
Servicio de Nefrología, Hospital Universitario Ramón y Cajal, Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Demographic and clinical characteristics of all the patients and according to etiologic subgroups.
Table 2. Demographic and clinical characteristics and patient outcomes according to study periods.
Table 3. Uni- and multivariate Cox regression models for mortality.
Show moreShow less
Abstract
Introduction

The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis with renal involvement are associated with high morbi-mortality. In this study we analyse if the prognosis of these diseases have improved in recent years, and which factors influence the outcomes.

Material and methods

Retrospective single-centre observational study, which included all patients diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis with renal involvement in the last 25 years. Demographic, clinical and biochemical parameters of prognostic interest were recorded. The differences between four chronological periods were analysed, along with the determinants of a poor outcome (death or end-stage renal disease).

Results

Eighty-nine patients were included (mean age 64±15 years). Sixty-four patients (72%) had microscopic polyangiitis and 25 (28%) granulomatosis with polyangiitis.

During the study period, 37 (42%) patients died. Through Cox regression analysis, the best determinants of mortality were the initial glomerular filtration rate (HR 0.911; p=0.003), Charlson comorbidity index (HR 1.513; p<0.0001) and tobacco smoking (HR 1.816; p=0.003).

35% developed end-stage renal disease, and the best determinants (by competing-risk regression) were: initial glomerular filtration rate (sub-hazard ratio [SHR]: 0.791; p<0.0001), proteinuria (SHR: 1.313; p<0.0001), and smoking status (SHR: 1.848; p=0.023).

No differences were found in patients’ mortality or renal survival between the different study periods.

Conclusions

Prognosis of anti-neutrophil cytoplasm antibodies vasculitis with renal involvement treated with conventional immunosuppressive therapy remains unsatisfactory, and continues to have increased long-term complications and mortality.

Keywords:
Anti-neutrophil cytoplasm antibodies
Granulomatosis with polyangiitis
Microscopic polyangiitis
Mortality
Renal vasculitis
Resumen
Introducción

Las vasculitis con anticuerpos contra el citoplasma de neutrófilo con afectación renal se asocian con una elevada morbimortalidad. En este estudio se analiza si el pronóstico de estas vasculitis ha mejorado en los últimos años, y cuáles son los factores que condicionan su evolución.

Material y métodos

Estudio retrospectivo de observación que incluyó a pacientes con poliangitis microscópica y granulomatosis con poliangitis con afectación renal diagnosticados en nuestro hospital durante los últimos 25 años. Se recogieron los parámetros demográficos, clínicos y bioquímicos de interés pronóstico, y se analizaron las diferencias según 4 períodos cronológicos, así como los determinantes de una peor evolución (muerte o insuficiencia renal terminal).

Resultados

Se incluyeron 89 pacientes (edad media 64±15 años). Sesenta y cuatro pacientes (72%) presentaban poliangitis microscópica y 25 (28%) granulomatosis con poliangitis.

Durante el período de estudio, 37 (42%) pacientes fallecieron. Mediante análisis de regresión de Cox, los determinantes de mortalidad fueron el filtrado glomerular basal (HR 0,911; p=0,003), índice de Charlson (HR 1,513; p<0,0001) y exposición al tabaco (HR 1,816; p=0,003).

El 35% desarrolló insuficiencia renal terminal. Los mejores determinantes de este acontecimiento (en competencia de riesgo por muerte) fueron: filtrado glomerular basal (sub-hazard ratio [SHR]: 0,791; p<0,0001), proteinuria (SHR: 1,313; p<0,0001), y hábito tabaco (SHR: 1,848; p=0,023).

No se observaron diferencias en la supervivencia total o renal en los diferentes períodos estudiados.

Conclusiones

El pronóstico de las vasculitis con anticuerpos contra el citoplasma de neutrófilo con afectación renal y tratamiento inmunosupresor convencional sigue siendo desfavorable, asociándose con numerosas complicaciones y elevada mortalidad.

Palabras clave:
Anticuerpos contra el citoplasma de neutrófilo
Granulomatosis con poliangitis
Poliangitis microscópica
Mortalidad
Vasculitis renal

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos